Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BDP9066 + FRAX1036 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BDP9066 | CS-0040570|A16874 | BDP9066 selectively inhibits MRCK kinases, therefore results in inhibition of motility and viability of tumor cells (PMID: 29382705). | ||
FRAX1036 | FRAX-1036 | PAK1 Inhibitor 11 | FRAX1036 is an inhibitor of group I PAKs (PAK1, PAK2, and PAK3), which may result in increased tumor cell apoptosis and sensitivity to microtubule-targeted agents (PMID: 25902869). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|